{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:17:10Z","timestamp":1781543830221,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jns.2008.03.022","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T08:12:40Z","timestamp":1210666360000},"page":"39-41","source":"Crossref","is-referenced-by-count":38,"title":["The effects of natalizumab on the innate and adaptive immune system in the central nervous system"],"prefix":"10.1016","volume":"274","author":[{"given":"Olaf","family":"St\u00fcve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2008.03.022_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1527-3458.2007.00003.x","article-title":"Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases","volume":"13","author":"Stuve","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"4","key":"10.1016\/j.jns.2008.03.022_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-Demasters","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jns.2008.03.022_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jns.2008.03.022_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jns.2008.03.022_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"Stuve","year":"2006","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.jns.2008.03.022_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.63.10.1383","article-title":"Altered CD4+\/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis","volume":"63","author":"Stuve","year":"2006","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jns.2008.03.022_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1750-3639.1991.tb00646.x","article-title":"Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation","volume":"1","author":"Hickey","year":"1991","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.jns.2008.03.022_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jns.2008.03.022_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2008.03.022_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.62.2.258","article-title":"Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis","volume":"62","author":"Monson","year":"2005","journal-title":"Arch Neurol"},{"issue":"Pt11","key":"10.1016\/j.jns.2008.03.022_bib11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/124.11.2169","article-title":"Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis","volume":"124","author":"Cepok","year":"2001","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2008.03.022_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0404.1985.tb03195.x","article-title":"T-cell subsets in multiple sclerosis: relationships between peripheral blood and cerebrospinal fluid","volume":"71","author":"Zaffaroni","year":"1985","journal-title":"Acta Neurol Scand"},{"issue":"2\u00ad3","key":"10.1016\/j.jns.2008.03.022_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(88)90164-6","article-title":"T-cell subsets in the cerebrospinal fluid and blood of patients with multiple sclerosis","volume":"20","author":"Kolmel","year":"1988","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.jns.2008.03.022_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.1988.tb05895.x","article-title":"The imbalance in CSF T cell subsets in active multiple sclerosis","volume":"77","author":"Matsui","year":"1988","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.jns.2008.03.022_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-510X(92)90193-O","article-title":"T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients","volume":"108","author":"Scolozzi","year":"1992","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.jns.2008.03.022_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20859","article-title":"Natalizumab effects on immune cell responses in multiple sclerosis","volume":"59","author":"Niino","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T20:29:24Z","timestamp":1546028964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0022510X08001603"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.03.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}